WOOJUNG BIO Inc (215380) — Financial Flexibility Index
WOOJUNG BIO Inc (215380) has a Financial Flexibility Index of -0.02x as of March 2026. Free cash flow of ₩-1.50 Billion (operating CF ₩-1.51 Billion minus capex ₩17.00 Million) represents 0% of total liabilities (₩98.45 Billion). Check how aggressively does WOOJUNG BIO Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
WOOJUNG BIO Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for WOOJUNG BIO Inc across 10 annual periods. For the full cash flow conversion analysis, see WOOJUNG BIO Inc cash flow conversion.
Annual Financial Flexibility Index for WOOJUNG BIO Inc (2016–2025)
Year-by-year free cash flow to debt coverage for WOOJUNG BIO Inc. Explore 215380 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | ₩-371.20 Million | ₩-630.50 Million | ₩63.42 Billion | ▲ +53.2% |
| 2024 | -0.01x | ₩-816.92 Million | ₩-1.13 Billion | ₩65.33 Billion | ▲ +59.1% |
| 2023 | -0.03x | ₩-2.33 Billion | ₩-3.22 Billion | ₩76.36 Billion | ▼ -114.3% |
| 2022 | 0.21x | ₩13.92 Billion | ₩2.50 Billion | ₩65.28 Billion | ▼ -61.9% |
| 2021 | 0.56x | ₩38.41 Billion | ₩1.73 Billion | ₩68.68 Billion | ▲ +225.0% |
| 2020 | 0.17x | ₩7.19 Billion | ₩-8.57 Billion | ₩41.78 Billion | ▲ +124.9% |
| 2019 | 0.08x | ₩2.37 Billion | ₩208.72 Million | ₩30.97 Billion | ▼ -56.9% |
| 2018 | 0.18x | ₩4.19 Billion | ₩-483.80 Million | ₩23.61 Billion | ▲ +304.0% |
| 2017 | -0.09x | ₩-1.14 Billion | ₩-2.38 Billion | ₩13.07 Billion | ▲ +1.7% |
| 2016 | -0.09x | ₩-126.76 Million | ₩-1.46 Billion | ₩1.43 Billion | — |